Freemelt (FREEM) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
2 Jun, 2026Financial and operational highlights
Revenue increased 162% year-over-year, with 42 machines deployed as of March end.
Over 30 paid customer projects since 2024, focused on serial production applications.
New chapter aims to scale by integrating 3D printing with finishing, machining, and quality control for certified parts.
Addressable market estimated at EUR 41–51 billion, targeting MedTech, defense, and energy sectors.
SEK 36 million warrant subscription launched to fund commercialization and pipeline growth.
Sector and customer developments
Secured follow-on order from a leading Swedish defense customer and completed copper project with Saab.
Fusion for Energy tungsten tile work progressing, with follow-on order from UKAEA.
Two orthopedic OEMs running proof of concepts on eMELT industrial machine in MedTech.
Collaboration with Saab includes research on copper and potential tungsten applications.
Technology and production strategy
Technology validated for extreme materials like tungsten, copper, and titanium.
Over 35 materials validated with customer collaboration.
Initial tungsten parts production to be based in Gothenburg, with potential regional expansion.
Differentiated go-to-market: machine sales to mature industries, part production for less mature sectors.
Latest events from Freemelt
- First industrial eMELT sale, OEM order, and machine sales growth amid ongoing losses.FREEM
Q3 20248 Jul 2026 - Q2 saw high activity, new orders, and strategic partnerships despite a wider loss.FREEM
Q2 20248 Jul 2026 - Record sales, fusion breakthroughs, and China entry drive growth in AM and medtech.FREEM
Investor Update1 Jul 2026 - Q1 net sales rose 116% YoY, with strong margins and key sector collaborations advancing.FREEM
Q1 20265 May 2026 - Sales up 172% to SEK 54.5m, installed base up 40%, and strong growth in key sectors.FREEM
Q4 202519 Feb 2026 - Industrial 3D printing momentum grows, targeting SEK 1 billion sales by 2030.FREEM
ABGSC Investor Days11 Jan 2026 - Strong Q4 growth, major orders, and capital raise drive expansion in core sectors.FREEM
Q4 202423 Dec 2025 - Record Q2 sales and global expansion drive strong growth and order intake.FREEM
Q2 202523 Nov 2025 - Record order book and SEK 90M rights issue drive growth in defense, energy, and MedTech.FREEM
Q1 202521 Nov 2025